Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 31, 2023 19:27 ET | Source: Assertio Holdings, Inc.

Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction

Combination of Assertio’s Omni-Channel Digital Sales Capabilities and ROLVEDON In-Person Commercial Team to Enhance Market Access and Growth Across All Products Transaction Expected to be...
July 27, 2023 16:01 ET | Source: Assertio Holdings, Inc.

Assertio Holdings, Inc. Announces Favorable Vote on Proposed Acquisition of Spectrum Pharmaceuticals

Stockholders From Both Assertio and Spectrum Have Overwhelmingly Voted in Support of the Transaction Transaction Expected to be Significantly Accretive to Assertio in 2024 LAKE FOREST, Ill. and...
July 03, 2023 11:37 ET | Source: Moore Kuehn

Moore Kuehn Encourages SYNH, SPPI, ARNC and EMBK Investors to Contact Law Firm

NEW YORK, July 03, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
April 26, 2023 17:41 ET | Source: Monteverde & Associates PC

ALERT: The M&A Class Action Firm Continues the Investigation of the Merger – MYBF, RXDX, SPPI, TRTN

NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
April 25, 2023 06:00 ET | Source: Assertio Holdings, Inc.; Spectrum Pharmaceuticals, Inc.

Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction

Complementary Commercial Growth Platforms Anticipated to Accelerate ROLVEDON™ (eflapegrastim-xnst) Injection Profitability and Diversify Revenue Streams Combination of Assertio’s Omni-Channel...
January 10, 2023 19:15 ET | Source: The Rosen Law Firm PA

ROSEN, A TOP RANKED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action– SPPI

NEW YORK, Jan. 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between...
January 02, 2023 19:30 ET | Source: The Rosen Law Firm PA

ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in First Filed Securities Class Action Initiated by the Firm– SPPI

NEW YORK, Jan. 02, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between...
December 23, 2022 17:28 ET | Source: The Rosen Law Firm PA

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPPI

NEW YORK, Dec. 23, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between...
December 20, 2022 17:51 ET | Source: Kaplan Fox & Kilsheimer LLP

Kaplan Fox Reminds Investors with Losses in Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) of Upcoming Lead Plaintiff Deadline

NEW YORK, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) filed a proposed class action suit in the United States District Court for the Southern District of...
November 01, 2021 12:15 ET | Source: The Law Offices of Frank R. Cruz

DEADLINE ALERT for SPPI and LDI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Nov. 01, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...

Next Page keyboard_arrow_right